在与阿尔茨海默氏症相关的神经炎症中,eicosanoid信号传递与阿尔茨海默氏症相关
Koppada Lohitaksha1, Deepika Kumari2, Manas Shukla3
1School of Chemistry, University of Hyderabad, Hyderabad, India.
European journal of pharmacology
|May 31, 2024
概括
脂质代谢物Eicosanoids在阿尔茨海默氏症 (AD) 中发挥双重作用,通过影响大脑免疫力. 针对eicosanoid信号提供了潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 生物化学 生化学
背景情况:
- 阿尔茨海默病 (AD) 是一种主要的神经退行性疾病,其特点是粉样斑块,团和神经炎症.
- 自由脂质及其衍生物,特别是来自酸 (AA) 的eicosanoids,都与AD的发病有关.
- 伊可索诺伊德信号对神经炎症的影响表明,在阿尔茨海默病的发展中具有复杂的双重作用.
研究的目的:
- 审查eicosanoids在神经元功能和阿尔茨海默病中的功能障碍中的复杂参与.
- 探索eicosanoids在调节神经炎症和AD进展中的多方面的作用.
- 评估针对阿尔茨海默症治疗的eicosanoid信号通路的治疗潜力.
主要方法:
- 关于eicosanoids,神经炎症和阿尔茨海默病的研究的综合文献综述.
- 对大脑中eicosanoid产生和信号的分子机制的分析.
- 对针对eicosanoid通路的临床前和临床数据的评估.
主要成果:
- 在AD的背景下,eicosanoids表现出促炎和抗炎的作用.
- 伊可索诺伊德信号通路显著影响微质激活和神经元健康.
- 驱动eicosanoids在AD中的双重作用的精确分子机制仍然不完全理解.
结论:
- 伊可索诺伊德在脂质代谢,神经炎症和阿尔茨海默病之间具有关键的联系.
- 针对特定的eicosanoid信号通路可能为AD提供新的治疗途径.
- 需要进一步的研究来阐明复杂的机制和优化治疗策略.
关键词:
阿尔茨海默氏症 (AD) 是一种疾病.阿拉基酸 是一种循环氧化基因酶 (Cyclooxygenase) 是一种埃可索索诺酸是什么类型的莱科特里昂类动物 (Leukotrienes) 是一种脂氧基因酶的使用方法神经炎症是一种神经炎症.前列腺腺中的前列腺腺素.在SPM中,可以使用SPM.类型: 类型: 血栓素 类型: 血栓素更多相关视频
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
7.8K
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
821
相关概念视频
Alzheimer's Disease: Overview
462
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
462
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Alzheimer's Disease: Treatment
179
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
179
